博斯韦利亚提取物促进治疗和解决大鼠口腔的炎症
Wei Zhao1, Zhuoqun Jia1, Jiao Han1
1Department of Oral Medicine, First Hospital of Shanxi Medical University, Taiyuan, China.
概括
博斯韦利亚提取物通过减少炎症和促进愈合,有效治疗复发性口腔. 它通过通过PPARγ激活调节巨细胞极化而起作用,为口腔治疗提供了一个新的治疗途径.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 自然产品 自然产品
背景情况:
- 复发的口腔会导致严重的疼痛和降低生活质量.
- 目前治疗口腔的方法往往是不够的.
- 博斯韦利亚的抗炎性质表明,它对口腔有潜在的治疗益处.
研究的目的:
- 为了研究博斯韦利亚在复发性口腔的治疗潜力.
- 在口腔模型中阐明博斯韦利亚菌作用的潜在机制.
- 为了评估博斯韦利亚对炎症和组织愈合的影响.
主要方法:
- 网络药理学确定了博斯韦利亚的活性成分和点.
- 在老鼠中建立了一个口腔的模型,并用博斯韦利亚提取物进行治疗.
- 分析了巨细胞两极分化,PPARγ激活和炎症标志物.
主要成果:
- 博斯韦利亚提取物加速了大鼠的口腔愈和体重恢复.
- 组织学分析显示,炎症和组织胀减少.
- 博斯韦利亚促进了M2巨细胞的两极分化,并抑制了M1巨细胞,表明依赖PPARγ激活的抗炎作用.
结论:
- 博斯韦利亚提取物在口腔愈方面显示出显著的治疗潜力.
- 该机制涉及通过调节巨细胞极化来解决炎症.
- PPARγ激活是Boswellia抗效应的一个关键途径.
更多相关视频
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118
01:26Peptic Ulcer Disease IV: Management
66
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
66
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
333
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
333